Anne Dubin
Publication Details
-
Cisapride associated with QTc prolongation in very low birth weight preterm infants.
Pediatrics. 2001; (6): 1313-6
No systematic study has been performed to evaluate the effect of cisapride on the QT interval in premature infants. Cisapride, which has recently been withdrawn by the Food and Drug Administration and is no longer an approved therapy, was commonly used for preterm infant care to improve the advance of enteral feedings and to reduce reflux and associated apnea. Our aim was to evaluate the effect of recommended doses of cisapride on the QT interval in this population.
Help